Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/52798
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarschner S.-
dc.contributor.authorMukherjee S.-
dc.contributor.authorWatts M.-
dc.contributor.authorMin H.-
dc.contributor.authorBeale A.L.-
dc.contributor.authorO'brien J.-
dc.contributor.authorJuneja A.-
dc.contributor.authorTremmel J.-
dc.contributor.authorZaman S.-
dc.date.accessioned2025-01-06T02:50:28Z-
dc.date.available2025-01-06T02:50:28Z-
dc.date.copyright2023-
dc.date.issued2024-11-19en
dc.identifier.citationEuropean Heart Journal. Conference: European Society of Cardiology Congress, ESC 2023. Amsterdam Netherlands. 44(Supplement 2) (no pagination), 2023. Date of Publication: November 2023.-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/52798-
dc.description.abstractBackground: A woman's risk of cardiovascular disease (CVD) is substantially increased after a diagnosis of hypertensive disorders of pregnancy (HDP), gestational diabetes (GDM), or have had a small for gestational age (SGA) baby. However, evidence for models of care that mitigate CVD risk in women with these pregnancy-related conditions is lacking. Purpose(s): To assess the effectiveness of a Women's Heart Clinic (WHC) on blood pressure (BP) and lipid control in women with past pregnancy-related cardiovascular risk factors. Method(s): A six-month prospective cohort study of women aged 30-55 years with a past pregnancy diagnosis of HDP, GDM or an SGA baby. All women attended a multidisciplinary WHC comprising a cardiologist, a cardiac nurse, and a dietician, located in three cardiovascular healthcare service centers in Australia. Women were assessed at their first attendance of the WHC and at 6 months. The co-primary endpoints were: 1) BP<140/90mmHg or <130/80mmHg if diabetes mellitus and 2) total cholesterol to high density lipoprotein-cholesterol ratio (TC:HDL-C)<4.5. Result(s): 156 women were recruited with a mean age of 41.0+/-4.2 years, 68.6% Caucasian, 20.5% South/East Asian and 80.5% university educated. Women were a mean of 3.9+/-2.9 years from last delivery with 23.1% past HDP only, 60.3% GDM only, 13.5% both HDP and GDM and, 3.2% with an SGA baby. All women attended a WHC at least once, with 69.5% reviewed by a dietician. The proportion meeting BP target increased (69.2% to 80.5%, p=0.004); with no significant change in women meeting lipid targets (80.6% to 83.7%, p=0.182). Women had significant reductions in mean systolic BP (-6.9mmHg, 95% confidence interval (CI): -9.1,-4.7, p<0.001), body mass index (-0.6kg/m2, CI: -0.8,-0.3, p<0.001), LDL-cholesterol (-4.2mg/dL, CI: -8.2,-0.2, p=0.042) and total cholesterol (-4.6mg/dL, CI: -9.1,-0.2, p=0.042). Heart-healthy lifestyle significantly improved with increased fish/olive oil (36.5% to 51.0%, p=0.012) and decreased fast food consumption (33.8% to 11.0%, P<0.001), with more women meeting exercise recommendations (84.0% to 92.9%, p=0.025). Conclusion(s): Women at high risk for CVD due to past pregnancy-related conditions experienced significant improvements in multiple cardiovascular risk factors, after attending a Women's Heart Clinic. This female-specific cardiovascular healthcare model has the potential to improve long-term CVD outcomes for women.-
dc.relation.ispartofEuropean Heart Journal-
dc.subject.meshcardiologist-
dc.subject.meshcardiovascular disease-
dc.subject.meshdietitian-
dc.subject.meshgestational diabetes-
dc.subject.meshmaternal hypertension-
dc.subject.meshpreeclampsia-
dc.titleWomen's heart clinics to prevent cardiovascular disease in women with pregnancy-related risk factors: a prospective study.-
dc.typeConference Abstract-
dc.identifier.affiliationMonash University - School of Clinical Sciences at Monash Health-
dc.description.conferencenameEuropean Society of Cardiology Congress, ESC 2023-
dc.description.conferencelocationAmsterdam, Netherlands-
dc.type.studyortrialObservational study (cohort, case-control, cross sectional, or survey)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1093/eurheartj/ehad655.2622-
local.date.conferencestart2023-11-25-
dc.identifier.institution(Marschner, Min, Zaman) University of Sydney, Westmead Applied Research Centre, Sydney, Australia-
dc.identifier.institution(Mukherjee) Monash University, School of Clinical Sciences at Monash Health, Melbourne, Australia-
dc.identifier.institution(Watts, Beale, O'brien) Alfred Hospital, Department of Cardiology, Melbourne, Australia-
dc.identifier.institution(Juneja) Northern Hospital, Melbourne, Australia-
dc.identifier.institution(Tremmel) Stanford University School of Medicine, Department of Medicine (cardiovascular), Stanford, United States-
local.date.conferenceend2023-11-28-
dc.identifier.affiliationmh(Mukherjee) Monash University, School of Clinical Sciences at Monash Health, Melbourne, Australia-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeConference Abstract-
crisitem.author.deptCardiology (MonashHeart & Victorian Heart Institute)-
Appears in Collections:Conferences
Show simple item record

Page view(s)

24
checked on Mar 13, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.